VaxcytePCVX
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 323 institutions reported holding Vaxcyte Inc. (PCVX) in their 13F filings, down 6 from Q3 2024. 47 opened new positions and 60 sold out. The largest holders were FMR LLC ($1.1B), Vanguard Group Inc. ($979.2M) and BlackRock, Inc. ($909.1M). 9 famous investors held it, including Lee Ainslie (1.8% of Maverick Capital's portfolio), Stanley Druckenmiller (0.2% of Duquesne Family Office's portfolio) and David E. Shaw (0.1% of D. E. Shaw & Co.'s portfolio).
- Company
- Vaxcyte Inc.
- CUSIP
- 92243G108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 47 | $162.1M |
| Exits | 60 | $542.1M |
All 13F filers, Q3 2024 → Q4 2024: 17,613,265 shares bought and 13,415,981 shares sold, net +4,197,284 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 323 holders
| FMR LLC | 0.06% | Reduce -17.1% | 13,091,648 | $1.1B |
| Vanguard Group Inc. | 0.02% | Add +4.6% | 11,961,687 | $979.2M |
| BlackRock, Inc. | 0.02% | Add +4.1% | 11,106,069 | $909.1M |
| Janus Henderson Group PLC | 0.44% | Reduce -3.2% | 10,575,363 | $865.6M |
| Ra Capital Management, L.P. | 9.47% | No change | 8,689,190 | $711.3M |
| Capital Research Global Investors | 0.10% | Add +26.8% | 6,210,523 | $508.4M |
| State Street Corp. | 0.01% | Add +33.3% | 4,539,406 | $371.6M |
| Wellington Management Group LLP | 0.07% | Reduce -1.6% | 4,444,012 | $363.8M |
| T. Rowe Price Associates Inc. | 0.04% | Reduce -11.2% | 3,966,956 | $324.7M |
| Goldman Sachs Group Inc. | 0.05% | Add +229.7% | 3,129,604 | $256.2M |
| Franklin Resources Inc. | 0.07% | Add +3.0% | 2,869,332 | $234.9M |
| T. Rowe Price Investment Management, Inc. | 0.14% | Reduce -29.4% | 2,860,717 | $234.2M |
| Geode Capital Management, LLC | 0.02% | Add +3.8% | 2,802,888 | $229.5M |
| Westfield Capital Management Co. LP | 0.91% | Add +47.5% | 2,566,759 | $210.1M |
| Kynam Capital Management, LP | 12.62% | Add +124.8% | 2,336,796 | $191.3M |
| Alliancebernstein L.P. | 0.05% | Add +8.1% | 1,779,362 | $145.7M |
| JPMorgan Chase & Co. | 0.01% | Add +21.6% | 1,735,663 | $142.1M |
| Perceptive Advisors LLC | 3.92% | Reduce -15.3% | 1,718,417 | $140.7M |
| Commodore Capital LP | 9.75% | Add +76.6% | 1,625,000 | $133.0M |
| Paradigm Biocapital Advisors LP | 4.05% | Add +126.7% | 1,422,787 | $116.5M |
| Charles Schwab Investment Management Inc. | 0.02% | Add +3.5% | 1,341,773 | $109.8M |
| Jennison Associates LLC | 0.06% | Add +0.7% | 1,246,551 | $102.0M |
| Deutsche Bank AG | 0.04% | Add +5.6% | 1,212,706 | $99.3M |
| Maverick Capital | 1.77% | Add +23.1% | 1,201,898 | $98.4M |
| Avoro Capital Advisors LLC | 1.36% | No change | 1,175,000 | $96.2M |
| Driehaus Capital Management LLC | 0.79% | Reduce -32.2% | 1,166,833 | $95.5M |
| Invesco Ltd. | 0.02% | Reduce -11.1% | 1,166,054 | $95.5M |
| Northern Trust Corp. | 0.01% | Add +11.9% | 1,160,001 | $95.0M |
| Woodline Partners LP | 0.62% | Add +1.5% | 1,120,922 | $91.8M |
| Clearbridge Investments, LLC | 0.07% | Reduce -4.9% | 1,102,486 | $90.2M |
| Norges Bank | 0.01% | Reduce -1.1% | 1,100,286 | $90.1M |
| Pictet Asset Management Holding SA | 0.09% | Add +30.3% | 1,017,845 | $83.3M |
| Polar Capital Holdings Plc | 0.45% | Reduce -2.2% | 973,645 | $79.7M |
| D. E. Shaw & Co. | 0.08% | Add +83.2% | 775,653 | $63.5M |
| Novo Holdings A/S | 3.72% | No change | 750,000 | $61.4M |
| UBS Group AG | 0.01% | Add +560.2% | 736,561 | $60.3M |
| Ameriprise Financial Inc. | 0.02% | Add +104.7% | 716,773 | $58.7M |
| Pivotal bioVenture Partners Investment Advisor LLC | 38.91% | Add +10.1% | 703,834 | $57.6M |
| Morgan Stanley | 0.00% | Reduce -0.2% | 693,333 | $56.8M |
| American Century Companies Inc. | 0.03% | Add +14.4% | 605,267 | $49.5M |
| Allspring Global Investments Holdings, LLC | 0.08% | Add +70.8% | 593,523 | $49.4M |
| Ensign Peak Advisors, Inc | 0.09% | Add +7.2% | 586,128 | $48.0M |
| Brown Advisory Inc. | 0.06% | Add +25.3% | 556,209 | $45.5M |
| Frazier Life Sciences Management, L.P. | 1.84% | Reduce -38.7% | 539,405 | $44.2M |
| Nuveen Asset Management, LLC | 0.01% | Add +14.2% | 529,650 | $43.4M |
| Fred Alger Management, LLC | 0.20% | Reduce -58.0% | 523,007 | $42.8M |
| Lazard Asset Management LLC | 0.06% | New | 486,764 | $39.8M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.01% | Add +15.8% | 472,964 | $38.7M |
| Bank of America Corp. | 0.00% | Reduce -17.5% | 469,911 | $38.5M |
| Cormorant Asset Management, LP | 1.91% | Reduce -57.5% | 425,000 | $34.8M |
| Bank of New York Mellon Corp | 0.01% | Add +2.4% | 421,938 | $34.5M |
| TimesSquare Capital Management, LLC | 0.49% | Add +53.7% | 413,637 | $33.9M |
| Amundi | 0.01% | Reduce -6.4% | 406,928 | $33.0M |
| Hood River Capital Management LLC | 0.49% | New | 401,442 | $32.9M |
| Eventide Asset Management, LLC | 0.57% | No change | 383,454 | $31.4M |
| Citigroup Inc. | 0.03% | Add +71.9% | 379,208 | $31.0M |
| Squarepoint Ops LLC | 0.08% | Add +493.5% | 376,846 | $30.8M |
| Comerica Bank | 0.11% | Add +24.2% | 339,095 | $27.8M |
| TD Asset Management Inc | 0.02% | Reduce -8.8% | 333,756 | $27.3M |
| Federated Hermes, Inc. | 0.06% | Reduce -34.9% | 326,058 | $26.7M |
| Principal Financial Group Inc. | 0.01% | Add +486.2% | 308,939 | $25.3M |
| Victory Capital Management Inc. | 0.02% | Add +19.0% | 303,556 | $24.8M |
| Voya Investment Management LLC | 0.03% | Reduce -0.8% | 301,560 | $24.7M |
| Logos Global Management LP | 2.87% | No change | 300,000 | $24.6M |
| Tang Capital Management LLC | 1.62% | No change | 300,000 | $24.6M |
| Siren, L.L.C. | 1.08% | No change | 299,991 | $24.6M |
| Jane Street Group, LLC | 0.04% | Add +249.9% | 299,292 | $24.5M |
| Dimensional Fund Advisors LP | 0.01% | Add +115.3% | 293,706 | $24.0M |
| Twinbeech Capital LP | 0.39% | New | 279,944 | $22.9M |
| First Turn Management, LLC | 4.06% | Add +30.6% | 276,905 | $22.7M |
| Millennium Management | 0.02% | Reduce -7.3% | 276,578 | $22.6M |
| Raymond James Financial Inc. | 0.01% | — | 264,704 | $21.7M |
| Barclays PLC | 0.01% | Add +21.5% | 254,885 | $20.9M |
| Point72 Asset Management | 0.06% | Reduce -30.2% | 251,055 | $20.6M |
| Macquarie Group Ltd. | 0.02% | Add +18.8% | 248,034 | $20.3M |
| Lord, Abbett & Co. LLC | 0.07% | Reduce -21.3% | 245,891 | $20.1M |
| Deerfield Management Company, L.P. | 0.40% | No change | 225,000 | $18.4M |
| Aberdeen Group plc | 0.03% | Add +171.4% | 224,824 | $18.4M |
| Braidwell LP | 0.81% | Reduce -25.3% | 222,424 | $18.2M |
| Swiss National Bank | 0.01% | Add +21.3% | 219,000 | $17.9M |
| Saturn V Capital Management LP | 6.55% | Reduce -0.3% | 204,285 | $16.7M |
| Alyeska Investment Group, L.P. | 0.06% | Reduce -9.7% | 197,585 | $16.2M |
| California Public Employees Retirement System | 0.01% | Reduce -3.6% | 188,041 | $15.4M |
| Rhumbline Advisers | 0.01% | Add +4.7% | 171,814 | $14.1M |
| Artia Global Partners LP | 5.36% | Add +112.8% | 162,255 | $13.3M |
| Sei Investments Co. | 0.02% | Reduce -9.8% | 161,682 | $13.2M |
| Manufacturers Life Insurance Company, The | 0.01% | Add +1.0% | 158,528 | $13.0M |
| Segall Bryant & Hamill, LLC | 0.17% | Reduce -1.3% | 153,988 | $12.6M |
| Walleye Capital LLC | 0.13% | Add +154.8% | 148,356 | $12.1M |
| Rafferty Asset Management, LLC | 0.04% | Add +128.6% | 147,436 | $12.1M |
| Man Group plc | 0.04% | Add +878.8% | 142,426 | $11.7M |
| Citadel Advisors | 0.01% | Add +2316.6% | 141,781 | $11.6M |
| Prudential Financial Inc. | 0.01% | Add +32.2% | 127,771 | $10.5M |
| Eversept Partners, LP | 1.08% | New | 127,588 | $10.4M |
| Susquehanna International Group, LLP | 0.02% | Add +182.0% | 125,396 | $10.3M |
| Legal & General Group Plc | 0.00% | Add +24.3% | 123,664 | $10.1M |
| First Trust Advisors LP | 0.01% | Add +4.8% | 123,568 | $10.1M |
| Parkman Healthcare Partners LLC | 1.27% | Reduce -10.8% | 116,138 | $9.5M |
| Candriam S.C.A. | 0.05% | New | 114,110 | $9.3M |
| Russell Investments Group, Ltd. | 0.01% | Add +37.3% | 108,389 | $8.9M |
"% of holder's portfolio" is PCVX's weight in each manager's 13F, not the share of Vaxcyte Inc. the manager owns.